Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study.

Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study.

[This corrects the article DOI: 10.1371/journal.pone.0153461.].

Bibliographic Details
Main Authors:	Simina M Boca, Maki Nishida, Michael Harris, Shruti Rao, Amrita K Cheema, Kirandeep Gill, Difei Wang, Lin An, Robinder Gauba, Haeri Seol, Lauren P Morgenroth, Erik Henricson, Craig McDonald, Jean K Mah, Paula R Clemens, Eric P Hoffman, Yetrib Hathout, Subha Madhavan
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4951084?pdf=render

Similar Items

Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study.
by: Simina M Boca, et al.
Published: (2016-01-01)

Discovery of potential urine-accessible metabolite biomarkers associated with muscle disease and corticosteroid response in the mdx mouse model for Duchenne.
by: Mathula Thangarajh, et al.
Published: (2019-01-01)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
by: Michael Ogundele, et al.
Published: (2021-08-01)

Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys
by: Shefa Tawalbeh, et al.
Published: (2020-10-01)

Metabolomic and exome sequence analysis reveal novel molecular signatures associated with colorectal cancer relapse
by: Gauba Robinder, et al.
Published: (2012-10-01)

In Silico Discovery of Mitosis Regulation Networks Associated with Early Distant Metastases in Estrogen Receptor Positive Breast Cancers
by: Yuriy Gusev, et al.
Published: (2013-01-01)

In Silico Discovery of Mitosis Regulation Networks Associated with Early Distant Metastases in Estrogen Receptor Positive Breast Cancers
by: Yuriy Gusev, et al.
Published: (2013-02-01)

SNP2Structure: A Public and Versatile Resource for Mapping and Three-Dimensional Modeling of Missense SNPs on Human Protein Structures
by: Difei Wang, et al.
Published: (2015-01-01)

Current and emerging treatment strategies for Duchenne muscular dystrophy
by: Mah JK
Published: (2016-07-01)

Secretome Survey of Human Plexiform Neurofibroma Derived Schwann Cells Reveals a Secreted form of the RARRES1 Protein
by: Roger Packer, et al.
Published: (2012-07-01)

Proteomic profiling of glucocorticoid-exposed myogenic cells: Time series assessment of protein translocation and transcription of inactive mRNAs
by: Hoffman Eric P, et al.
Published: (2009-07-01)

A case study for cloud based high throughput analysis of NGS data using the globus genomics system
by: Krithika Bhuvaneshwar, et al.
Published: (2015-01-01)

Celiac disease in a boy with duchenne muscular dystrophy: A double jeopardy!
by: Indar K Sharawat, et al.
Published: (2020-01-01)

Genome-wide multi-omics profiling of colorectal cancer identifies immune determinants strongly associated with relapse
by: Subha eMadhavan, et al.
Published: (2013-11-01)

Modulation of Radiation Response by the Tetrahydrobiopterin Pathway
by: Rupak Pathak, et al.
Published: (2015-01-01)

Functional recovery of glycine receptors in spastic murine model of startle disease
by: Annamaria Molon, et al.
Published: (2006-02-01)

Delay in Diagnosis of Duchenne Muscular Dystrophy
by: Vamshi K Rao, et al.
Published: (2015-01-01)

Prednisone in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1991-04-01)

DISTROFI MUSKULAR DUCHENNE
by: Iskandar Syarif, et al.
Published: (2009-09-01)

Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989-05-01)

Genetic modifiers of respiratory function in Duchenne muscular dystrophy
by: Luca Bello, et al.
Published: (2020-05-01)

Echocardiographic Image Quality Deteriorates with Age in Children and Young Adults with Duchenne Muscular Dystrophy
by: Alyssa Power, et al.
Published: (2017-12-01)

A direct approach to estimating false discovery rates conditional on covariates
by: Simina M. Boca, et al.
Published: (2018-12-01)

Glucocorticoids for Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (2013-07-01)

Serum Transaminase in Duchenne Dystrophy
by: J Gordon Millichap
Published: (2011-03-01)

Brain Dystrophin in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995-10-01)

Genetics of Duchenne and Becker Dystrophies
by: J Gordon Millichap
Published: (1990-07-01)

Cerebral Abnormalities in Duchenne MD
by: J Gordon Millichap, et al.
Published: (2014-09-01)

Prednisone Therapy for Duchenne Dystrophy
by: J Gordon Millichap
Published: (2005-02-01)

Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995-02-01)

Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021-06-01)

Diagnosis delay of Duchenne Muscular Dystrophy Demora no diagnóstico da Distrofia Muscular de Duchenne
by: Alexandra Prufer de Queiroz Campos Araújo, et al.
Published: (2004-06-01)

The clinical course of Duchenne muscular dystrophy in the corticosteroid treatment era: a systematic literature review
by: Shelagh M. Szabo, et al.
Published: (2021-05-01)

Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study.
by: Edward C Smith, et al.
Published: (2020-09-01)

Variability and trends in corticosteroid use by male United States participants with Duchenne muscular dystrophy in the Duchenne Registry
by: Leslie Cowen, et al.
Published: (2019-05-01)

Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.
by: Andrea Barp, et al.
Published: (2015-01-01)

Regenerative biomarkers for Duchenne muscular dystrophy
by: Simon Guiraud, et al.
Published: (2019-01-01)

Prednisone-Treated Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1991-06-01)

Language Delay in Duchenne’s Muscular Dystrophy
by: J Gordon Millichap
Published: (2007-06-01)

Mortality cost of Duchenne muscular dystrophy
by: Erik Landfeldt, et al.
Published: (2017-04-01)